Randomized phase 3 study of panitumumab with FOLFIRI vs FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC)
- Peeters, M.
- Price, T.
- Hotko, Y.
- Cervantes, A.
- Ducreux, M.
- Andre, T.
- Chan, E.
- Lordick, F.
- Rong, A.
- Gansert, J.
ISSN: 1359-6349, 1878-1217
Año de publicación: 2009
Volumen: 7
Número: 3
Páginas: 10-10
Congreso: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology
Tipo: Aportación congreso